Synthetic Biology Market Size, Share & Trends Analysis Report By Product (Enzymes, Cloning Technologies Kits), By Technology (PCR, NGS), By Application (Non-healthcare, Healthcare), And Segment Forecasts, 2023 - 2032

Synthetic Biology Market Size, Share & Trends Analysis Report By Product (Enzymes, Cloning Technologies Kits), By Technology (PCR, NGS), By Application (Non-healthcare, Healthcare), And Segment Forecasts, 2023 - 2032

The global synthetic biology market size is expected to reach USD 71.51 billion by 2032, according to a new study by Polaris Market Research. The report “Synthetic Biology Market Size, Share & Trends Analysis Report By Product (Enzymes, Cloning Technologies Kits), By Technology, By Application, And Segment Forecasts, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rising demand for synthetic biology will rise as a result of the growing number of applications for therapeutic genome editing, multiplexed diagnostics, and cellular recording. The use of products made using synthetic biology methods in fields like energy and chemicals is also likely to have an impact on the market's overall development.

Due to the COVID-19 outbreak, the use of synthetic biology goods has increased over the past two years. Many significant pharmaceutical and biotechnology companies, as well as players in the synthetic biology industry, have increased their research efforts globally by adopting new techniques for developing test kits, therapies, and vaccines for COVID-19. One of the emerging technologies is synthetic biology, according to a study from the European Parliament.

The global market is expected to grow as research and development efforts are expanded across a variety of disciplines. In order to increase the utilisation of cheap inputs like waste and enhance performance of conventional biofuel production, players are using synthetic biology methods.

With the aim of providing effective, useful, and dependable tools to advance RNAi research, the company has a broad variety of knowledge and expertise to produce premium RNAi products, like shRNA clones and siRNA libraries.

Artificial intelligence (AI)/machine learning has lately emerged as a viable alternative to systems biology for the explanation of biological phenomena and the achievement of specific design goals in synthetic biology. Similar efforts to enhance and automate analysis and decision-making in these fields can be seen in the development of machine learning (ML) and artificial intelligence (AI) tools and methods currently being made in the biological and biotechnological fields. AI/ML is still a good choice for analysing system behaviour and boosting interest in synthetic biology applications.

Synthetic Biology Market Report Highlights

The oligonucleotide/oligo segment dominated the market in 2022. Oligonucleotides are the primary component in many molecular and synthetic biology applications. The growing use of targeted NGS, mutagenesis research, DNA computing, and CRISPR gene editing are the primary market drivers for the same.

The PCR market segment held the highest market share in 2022. The Polymerase Chain Reaction is one of the most crucial instruments for the identification and analysis of specific gene sequences. (PCR).

Biosciences Inc., Codexis Inc., Creative Biogene, CREATIVE ENZYMES, Enbiotix Inc., Illumina Inc., Merck Kgaa (Sigma-Aldrich Co. LLC), New England Biolabs, Euro fins Scientific, Novozymes, and Pareto Bio Inc. are a few of the main companies active in the global market.

Polaris Market Research has segmented the Synthetic Biology Market report based on product, technology, application and region:

Synthetic Biology, Product Outlook (Revenue - USD Billion, 2019 - 2032)

Oligonucleotide/Oligo Pools and Synthetic DNA

Enzymes

Cloning Technologies Kits

Xeno-Nucleic Acids

Chassis Organism

Synthetic Biology, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

NGS Technology

PCR Technology

Genome Editing Technology

Bioprocessing Technology

Other Technologies

Synthetic Biology, Application Outlook (Revenue - USD Billion, 2019 - 2032)

Healthcare

Non-Healthcare

Synthetic Biology, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa